“To say that we are pleased to add John to our Board of Advisors is a significant understatement,” noted Gerry Martin, CEO of ONIT Sciences. “
John’s very specific mix of financial and medical/biotech expertise will help ensure ONIT takes advantage of every opportunity available to us in this burgeoning market. His role will be particularly important as we move towards institutional financing and secure our position as a leader in the movement towards organic cannabis products and practices, particularly in the Health & Wellness and Medical cannabis markets.”
Mr. Stroh currently serves as Managing Director – HealthCare Team Leader at Tellson Investment Banking. He has raised over $2 billion in capital for client companies and advised on over 100 M&A/Strategic Partnering transactions. Prior positions included managing Director Investment Banking at Roth Capital Partners; Managing Director with John Nuveen & Co./U.S. Bancorp Piper Jaffray; President and CEO of Nanospectra Biosciences; CEO of Global Healthcare Advisors; and COO, CFO and SVP at Kadmus Pharmaceuticals. Mr. Stroh also served on the Board of Directors and was Chairman of the Finance Committee with Orange Coast Memorial Hospital.
“I am excited to join such an innovative and well-positioned company as ONIT Sciences,” said Mr. Stroh. “The cannabis and hemp markets are simply explosive right now, with new opportunities opening up globally. ONIT has the right team, the right product, and the right plan to really make a positive impact as market drivers push towards organic production. I am pleased to offer my advice and guidance as they execute on their strategies.”